smartpatient
smartpatient GmbH operates MyTherapy, the world's most widely used medication management app with 12M+ users, licensing it B2B to pharmaceutical companies to deploy configurable patient support programs, direct-to-patient activation campaigns, and real-world data analytics across 120+ countries.
- Company typePrivate
- Founded2012
- HeadquartersMunich, Germany
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What smartpatient does
smartpatient GmbH, founded in 2012 and headquartered in Munich, operates the MyTherapy medication management platform — described as the world's most widely used medication management app with 12M+ users across 120+ countries and 30+ languages. The platform provides medication reminders, symptom and health data tracking, appointment management, care-team integration, and e-prescription connectivity, and is certified under ISO 13485, ISO 27001, GDPR, and HIPAA, enabling configuration of modules as regulated Software as a Medical Device (SaMD) under EU MDR and US FDA frameworks.
The company monetizes primarily B2B by licensing MyTherapy to pharmaceutical companies (top customers include Novartis, Merck KGaA, Novo Nordisk, Lilly, Daiichi Sankyo, ALK, UCB, Pfizer, Bayer, AstraZeneca, Sanofi, Boehringer Ingelheim, Sandoz, and Danone) to deploy configurable Patient Support Programs, Direct-to-Patient activation campaigns, and a Data & Insights analytics layer that combines MyTherapy patient behavior with Redcare Pharmacy prescription and dispensing data across ~25M patients. Pricing mixes annual SaaS-style enterprise licensing with pay-for-performance (outcome-based) components. In March 2025 the company launched Mighty, a conversational AI health assistant embedded in MyTherapy, and in March 2026 it extended its ecosystem via a strategic partnership with arztkonsultation to integrate telemedicine and guideline-based prescribing into the platform.
Since January 2021 smartpatient has operated as a subsidiary of Redcare Pharmacy (formerly Shop Apotheke Europe), Europe's leading online pharmacy, giving it structural advantages in e-prescription fulfillment (including a Gematik-approved CardLink NFC integration) and pharmacy distribution that standalone vendors cannot replicate. The 90-person team spans Munich and a Warsaw shared-services subsidiary (Smartpatient Business Services Sp. z o.o.).
smartpatient firmographics
Firmographics- Name
- smartpatient
- Legal name
- smartpatient GmbH
- Website
- https://smartpatient.eu
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- smartpatient GmbH operates MyTherapy, the world's most widely used medication management app with 12M+ users, licensing it B2B to pharmaceutical companies to deploy configurable patient support programs, direct-to-patient activation campaigns, and real-world data analytics across 120+ countries.
- Ownership category
- akta.pro rank
smartpatient industry classification
Industry- Product category
- Digital Patient Engagement Software
- NAICS
- Services for the Elderly and Persons with Disabilities (624120), Offices of Physicians (except Mental Health Specialists) (621111)
- SIC
- Services-Health Services (8000), Services-Prepackaged Software (7372)
- akta.pro primary industry
- Chronic Condition Virtual Care & Disease Management (Payer-Sponsored) (HLALACAE)
- akta.pro secondary industries
- Chronic Condition Medication Programs (e.g., diabetes, hypertension) with Integrated Prescribing (HLALAIAH), Virtual Pharmacy & Medication Management Integration Platforms (HLALABAL), Prescription-Based Digital Clinics (Condition-Specific Rx Programs) (HLALAAAD)
Keywords
Where smartpatient is headquartered
LocationHeadquarters
- HQ city
- Munich
- HQ country
- Germany
- HQ region
- Europe
Offices2 records
Markets served
smartpatient business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- B2B Enterprise Licensing to Pharma: Pharmaceutical companies license the MyTherapy platform and configure customized patient support programs. Revenue is generated through platform licensing fees and program configuration services. The company offers performance-based models where payment is tied to predefined user actions, ensuring ROI for pharma partners.
- Data & Insights Services: Pharma partners access real-world patient data and insights generated from the platform, enabling evidence-driven strategic decisions around brand performance, patient behavior, and market dynamics.
- Patient Activation Campaigns: Performance-based patient activation campaigns across MyTherapy and Redcare Pharmacy ecosystems, with pricing tied to predefined user actions and engagement outcomes.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Others | Free patient-facing app |
| Subscription | Annual | Enterprise B2B Platform Licensing |
| Outcome Based/ Performance | Pay-as-you-go | Performance-based Campaigns |
Go-to-market motion2 records
Distribution channels5 records
Marketing channels6 records
smartpatient product offering
Product offeringCore offering
smartpatient develops and operates the MyTherapy platform, a medication management app used by over 12 million patients globally, which serves as digital infrastructure for pharmaceutical companies to deploy branded patient support programs, run direct-to-patient activation campaigns, and access real-world patient data and insights. The company licenses the platform to pharma partners, configures treatment-specific support modules, and integrates with Redcare Pharmacy's fulfillment network and telemedicine providers to deliver end-to-end digital care pathways.
Product overview
Smartpatient operates as a digital health ecosystem centered around the MyTherapy medication management platform (over 12 million users) and its parent company Redcare Pharmacy (Europe's leading online pharmacy). The offering is a platform-plus-modules architecture combining the core MyTherapy app with AI-powered patient support (Mighty), data analytics (Data & Insights), configurable patient support programs (PSP), and direct-to-patient marketing campaigns. The ecosystem integrates with telemedicine providers (arztkonsultation), pharmacy networks, and healthcare systems to deliver continuous patient support from diagnosis through treatment management.
Differentiator
Problem solved
Functional benefit
Brands
- MyTherapy: The world's most widely used medication management app with over 12 million users. MyTherapy helps patients manage medications, track health data, and stay on top of treatment routines. The platform includes features such as medication reminders, symptom tracking, appointment management, and integration with pharmacies.
- Mighty
Products and services
- MyTherapy Platform The world's most widely used medication management app with over 12 million users globally. It serves as the underlying platform that pharmaceutical partners license to deliver branded patient support, medication reminders, symptom tracking, appointment management, health data recording, and pharmacy connectivity.
- Mighty AI Health Assistant Conversational AI health assistant embedded within MyTherapy, providing patients with real-time support for treatment-related questions, medication guidance, and access to verified health information. Facilitated over 50,000 patient interactions in its first year with 47% focused on health-related queries.
- Data & Insights Platform Real-world patient data and analytics solution combining MyTherapy user data with Redcare Pharmacy prescription and dispensing data across approximately 25 million patients. Offers sales benchmarking, behavioral pattern analysis, reasoning data, and AI-powered predictive insights to pharmaceutical partners.
- Patient Support Programs (PSP) Configurable digital patient support programs built on the MyTherapy platform, enabling pharma partners to deploy branded, treatment-specific support including automated regimen and titration scheduling, gamification, injection site tracking, custom educational content, SaMD modules, and care team connectivity.
- Patient Activation Campaigns Direct-to-patient marketing campaigns enabling pharma to reach, educate, and activate patients with targeted, compliant campaigns across the combined MyTherapy and Redcare Pharmacy platform of 25M+ patients. Features precision targeting, behavioral science techniques, and performance-based pricing tied to predefined user actions.
- E-Prescription Integration Electronic prescription functionality enabling patients to retrieve e-prescriptions via NFC-enabled health insurance card (CardLink via Gematik) and order medications for home delivery through Redcare Pharmacy directly from MyTherapy.
Quantifiable outcome
- 85% higher adherence compared to baseline
- +9 more outcomes
Companies that use smartpatient
Customer profileNamed customers15 records
Segments4 records
Ideal customer profiles2 records
smartpatient technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
AI capability6 records
Feature6 records
smartpatient partnerships and signals
Strategic signalPartnerships
18 partnerships are on record, tiered core and minor.
- arztkonsultationcoreStrategic partnership to establish an integrated digital care pathway launching initially in clinical obesity. Combines MyTherapy's patient activation and medication management platform with arztkonsultation's telemedicine infrastructure. Aims to reduce time-to-diagnosis, shorten specialist waiting times, improve medication adherence, and create scalable model for additional chronic disease areas. The partnership is designed as indication-agnostic and expandable.
- Daiichi SankyocoreCollaboration to develop a digital support module within MyTherapy app for Nustendi patients with high LDL cholesterol levels (hypercholesterolemia). The module incorporates reminders, motivational prompts, health data trackers, and lifestyle tips to improve treatment adherence and reduce cardiovascular risk events such as heart attack and stroke.
- ALKcoreThree-year collaboration to improve treatment adherence in allergy immunotherapy through digital patient support programs built on MyTherapy. Programs have shown high patient engagement with 95% understanding the importance of long-term therapy and over 90% feeling well educated. Partnership supports thousands of allergy patients across Europe.
- Merck KGaAcoreExpanded strategic partnership with Merck KGaA, Darmstadt, Germany spanning more than 5 years across multiple therapeutic areas. Programs operate across five continents. Includes MS digital companion and new cardiovascular disease digital companion. Features remote monitoring and SaMD extensions. Extended from specialty care to primary care setting.
- Redcare Pharmacy (formerly Shop Apotheke Europe)coresmartpatient was acquired by Redcare Pharmacy in January 2021. This partnership marked a key milestone enabling holistic patient-centric experience connecting e-prescription, fulfillment, and ongoing digital support within one seamless ecosystem. Redcare Pharmacy is Europe's leading online pharmacy.
- NovartiscorePartnership with Novartis dates back to 2018, making it one of the longest-standing collaborations. Companies have worked closely on developing impactful patient support solutions so patients on Novartis medicines have support to better manage their conditions. Global Patient Solutions and Services leadership involved.
- Novo NordiskcorePioneering digital support program for people living with obesity in Germany. Smartpatient and Novo Nordisk introduced a digital support model for obesity care, combining patient activation with medication management support.
- LillycoreObesity program collaboration with Lilly scaling patient-centric digital health solutions. Partnership marks one year of collaboration with demonstrated impact.
- UCBcorePartnership leveraging digital health solutions to make patient support more accessible for patients living with severe diseases. Head of Immunology Germany leads collaboration for Germany market.
- Boehringer IngelheimminorLogo listed as trusted pharma partner.
- PfizerminorLogo listed as trusted pharma partner.
- AstraZenecaminorLogo listed as trusted pharma partner.
- BayerminorLogo listed as trusted pharma partner.
- SanofiminorLogo listed as trusted pharma partner.
- SandozminorLogo listed as trusted pharma partner.
- DanoneminorCollaboration bringing patients closer to nutritional therapy support through MyTherapy. Gains valuable insights into patient needs and challenges for more targeted and personalized support in nutritional therapy.
- Berlin-ChemieminorLogo listed as trusted pharma partner.
- Cancer Support CommunityminorPartnership for advancing breast and prostate cancer patient support through MyTherapy platform.
Scale indicators17 records
Recent moves7 records
Expansion highlights5 records
smartpatient competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Key highlights2 records
Customer concentration
smartpatient social profiles
Digital presencesmartpatient compliance and trust
Trust signalCompliance4 records
smartpatient financial estimates
Financial estimateRevenue estimate
Valuation estimate
smartpatient leadership team
Management profileNumber of profiles
Profiles9 records
smartpatient subsidiaries and ownership
Company hierarchySubsidiaries1 record
smartpatient funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
smartpatient M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about smartpatient
What does smartpatient do?
smartpatient develops and operates the MyTherapy platform, a medication management app used by over 12 million patients globally, which serves as digital infrastructure for pharmaceutical companies to deploy branded patient support programs, run direct-to-patient activation campaigns, and access real-world patient data and insights. The company licenses the platform to pharma partners, configures treatment-specific support modules, and integrates with Redcare Pharmacy's fulfillment network and telemedicine providers to deliver end-to-end digital care pathways.
Is smartpatient a public or private company?
smartpatient is a private company. It is classified as corporate owned and is currently operating.
When was smartpatient founded?
smartpatient was founded in 2012. It employs 51 to 100 people.
Where is smartpatient based?
smartpatient is headquartered in Munich, Germany, in the Europe region.
How does smartpatient make money?
Three revenue lines are on record. B2B Enterprise Licensing to Pharma is the primary driver. The others are data & Insights Services and patient Activation Campaigns.
Does smartpatient have an API?
No public API is recorded for smartpatient.
What industry is smartpatient in?
smartpatient's product category is Digital Patient Engagement Software. Its primary akta.pro industry code is HLALACAE, Chronic Condition Virtual Care & Disease Management (Payer-Sponsored), with a secondary code of HLALAIAH, Chronic Condition Medication Programs (e.g., diabetes, hypertension) with Integrated Prescribing. Its NAICS code is 624120 and its SIC code is 8000.